西维斯健康CVS Health（CVS）2025年第二季度财报（10-Q）「NYSE」（英文版）（204页）.pdf

1、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549 FORM 10-Q(Mark One)QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended June 30,2025or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT O

2、F 1934For the transition period from _ to_Commission File Number:001-01011CVS HEALTH CORPORATION(Exact name of registrant as specified in its charter)Delaware05-0494040(State or other jurisdiction of incorporation or organization)(I.R.S.Employer Identification No.)One CVS Drive,Woonsocket,Rhode Isla

3、nd02895(Address of principal executive offices)(Zip Code)Registrants telephone number,including area code:(401)765-1500Former name,former address and former fiscal year,if changed since last report:N/ASecurities registered pursuant to Section 12(b)of the Act:Title of each classTrading Symbol(s)Name

4、of each exchange on which registeredCommon Stock,par value$0.01 per shareCVSNew York Stock ExchangeIndicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934 duringthe preceding 12 months(or for such shorter

5、 period that the registrant was required to file such reports),and(2)has been subject to such filing requirements forthe past 90 days.Yes NoIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 ofRegulatio

6、n S-T(232.405 of this chapter)during the preceding 12 months(or for such shorter period that the registrant was required to submit such files).Yes NoIndicate by check mark whether the registrant is a large accelerated filer,an accelerated filer,a non-accelerated filer,a smaller reporting company,or